Accordingly, the metabolic effects of VSG in subjects with obesity are significantly smaller than those of RYGB and BPD but also smaller than those of a low-fat diet showing the importance of the upper gut bypass as well as the relevance of reducing fat intake in the amelioration of the metabolic derangement associated with insulin resistance. This evidence concerns the gene INS and obesity disorder.